F.D.A. Rejects Levadex, a New Drug for Migraines
Tuesday, April 16, 2013 - 20:10
in Health & Medicine
The drug maker Allergan said that the Food and Drug Administration had declined to approve Levadex because of concerns about the manufacturing of the inhaler used to dispense it.